SPONSOR
Per-Ola Carlsson
Total Trials
1
Recruiting
1
Phases
EARLY_Phase 1
Conditions studied: Type1diabetes
Per-Ola Carlsson is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Type1diabetes.
The trial portfolio spans EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Per-Ola Carlsson
How many clinical trials has Per-Ola Carlsson sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Per-Ola Carlsson, of which 1 are actively recruiting participants. These trials cover conditions including Type1diabetes. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Per-Ola Carlsson research focus on?
Per-Ola Carlsson clinical trials span Type1diabetes. The research pipeline includes EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Per-Ola Carlsson clinical trial?
To participate in a Per-Ola Carlsson trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Per-Ola Carlsson trials with current recruitment status updated daily.
Clinical Trials by Per-Ola Carlsson
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology